EUVIMEDEUVIMED entdecken
Crossref

Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors

Ismail Koyuncu iD, Ebru Temiz iD, Eray Metin Güler iD, Mustafa Durgun iD, Ozgür Yuksekdag iD, Simone Giovannuzzi iD, Claudiu T Supuran iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202300680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Ismail Koyuncu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey Tel. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase IX, Sulfonamides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines efficiency of a newly synthesized sulfonamide derivative 2‐bromo‐ N ‐(4‐sulfamoylphenyl)propanamide (MMH‐1) on the inhibition of Carbonic Anhydrase IX (CA IX), which is overexpressed in many solid tumors including breast cancer. The inhibitory potential of MMH‐1 compound against its four major isoforms, including cytosolic isoforms h CA I and II, as well as tumor‐associated membrane‐bound isoforms h CA IX and XII, was evaluated. To this context, the cytotoxic effect of MMH‐1 on cancer and normal cells was tested and found to selectively affect MDA‐MB‐231 cells. MMH‐1 reduced cell proliferation by holding cells in the G0/G1 phase (72 %) and slowed the cells′ wound healing capacity. MMH‐1 inhibited CA IX under both hypoxic and normoxic conditions and altered the morphology of triple negative breast cancer cells. In MDA‐MB‐231 cells, inhibition of CA IX was accompanied by a decrease in extracellular pH acidity (7.2), disruption of mitochondrial membrane integrity (80 %), an increase in reactive oxygen levels (25 %), and the triggering of apoptosis (40 %). In addition, the caspase cascade (CASP‐3, ‐8, ‐9) was activated in MDA‐MB‐231 cells, triggering both the extrinsic and intrinsic apoptotic pathways. The expression of pro‐apoptotic regulatory proteins (Bad, Bax, Bid, Bim, Cyt‐c, Fas, FasL, TNF‐a, TNF‐R1, HTRA, SMAC, Casp‐3, ‐8, P21, P27, and P53) was increased, while the expression of anti‐apoptotic proteins, apoptosis inhibitor proteins (IAPs), and heat shock proteins (HSPs) (Bcl‐2, Bcl‐w, cIAP‐2, HSP27, HSP60, HSP70, Survivin, Livin, and XIAP) was decreased. These results propose that the MMH‐1 compound could triggers apoptosis in MDA‐MB‐231 cells via the pH/MMP/ROS pathway through the inhibition of CA IX. This compound is thought to have high potential and promising anticancer properties in the treatment of aggressive tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXSulfonamidesHumansAntigens, NeoplasmApoptosisCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

ApoptosisCA IXMDA-MB-231MMH-1SulfonamideTriple-Breast Cancer

Substanzen

Antigens, NeoplasmAntineoplastic AgentsCA9 protein, humanCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXSulfonamides

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey Tel.
  • Program of Medical Promotion and Marketing, Health Services Vocational School, Harran University, Sanliurfa, Turkey.
  • Department of Medical Biochemistry, Faculty of Hamidiye Medicine, University of Health Sciences, Istanbul, Turkey.
  • Department of Chemistry, Faculty of Arts and Sciences, Harran University, Sanliurfa, Turkey Tel.
  • Department of Neurofarba, Section of Pharmaceutical and Nutriceutical Sciences, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy Tel.

ORCID-Profile: Ismail Koyuncu, Ebru Temiz, Eray Metin Güler, Mustafa Durgun, Ozgür Yuksekdag, Simone Giovannuzzi, Claudiu T Supuran

Zitieren

APA

Koyuncu, I., Temiz, E., Güler, E. M., Durgun, M., Yuksekdag, O., Giovannuzzi, S., & Supuran, C. T. (2024). Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem. https://doi.org/10.1002/cmdc.202300680

Vancouver

Koyuncu I, Temiz E, Güler EM, Durgun M, Yuksekdag O, Giovannuzzi S, et al. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem. 2024. doi:10.1002/cmdc.202300680

BibTeX
@article{Koyuncu2024,
  author = {Koyuncu, Ismail and Temiz, Ebru and Güler, Eray Metin and Durgun, Mustafa and Yuksekdag, Ozgür and Giovannuzzi, Simone and Supuran, Claudiu T},
  title = {Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202300680}
}
Kostenlos starten →